SIGN2024EN
SIGN 170: Optimising glycaemic control in people with type 1 diabetes
Zusammenfassung
Optimising glycaemic control in
people with type 1 diabetes
Quick reference guide
March 2024
SI GN170
This Quick Reference Guide provides a summary
of the main recommendations in SIGN 170 Optimising
glycaemic control in people with type 1 diabetes. Recommendations R have been adapted from published
evidence-based clinical guidance. Details of the publications from which these
recommendations have been sourced can be found
in the toolkit, available on the SIGN website:
www.sign.ac.uk
2
En
Kerninformationen
R Referrals for treatment of depression or anxiety should be made to mental health
services with experience using cognitive behavioural therapy or other evidence-based
treatment approaches in conjunction with collaborative care with the person’s diabetes
treatment team.
3
R To minimise inequalit...
R Offer real-time continuous glucose monitoring to all children and young
people with type 1 diabetes, alongside education to support children
and young people and their families and carers to use it. R The continuation of CGM and/or continuous subcutaneous insulin infusion should be
considered i...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchen